Dr. Rountree discusses research-based strategies for utilizing photobiomodulation with Parkinson's patients, including improvements in symptoms observed in objective testing and subjective perception. The correlation between patients' perception of improvement and treatment continuation is explored. The podcast also delves into the findings of a study on using photobiomodulation therapy for Parkinson's, the potential of laser therapy, and its benefits on various disorders. Safe and effective use of laser light therapy for treating Parkinson's, including options for home treatment, is discussed.
Photobiomodulation therapy showed significant improvements in mobility, fine motor skills, balance, and cognition for Parkinson's patients over a 12-week period and up to one year after treatment.
Photobiomodulation therapy, also known as laser therapy, has systemic effects by activating DNA transcription factors and anti-inflammatory effects on immune cells, making it beneficial for various disorders.
Deep dives
Study findings: Improvements in clinical signs of Parkinson's disease
A prospective proof of concept study titled 'Improvements in clinical signs of Parkinson's disease using photobiomodulation' showed promising results. The study aimed to delay the progression and improve the signs and symptoms of Parkinson's disease, a progressive neurological condition. Over a 12-week period, 12 participants received transcranial, intranasal, neck, and abdominal photobiomodulation therapy. Significant improvements were observed in mobility, fine motor skills, balance, and cognition at the 12-week mark and up to one year after treatment. The study demonstrated the potential of photobiomodulation to enhance the quality of life for Parkinson's patients.
Safety and systemic effects of photobiomodulation
Photobiomodulation, also known as laser therapy, was shown to be safe and non-invasive in treating Parkinson's disease. The therapy increases ATP production and regulates cellular signaling pathways, influencing gene transcription. Beyond the local effects, photobiomodulation has systemic effects by activating DNA transcription factors. Studies highlight its benefits in various disorders, including wound healing, diabetic ulcers, pain reduction, inflammatory conditions like lung inflammation, osteoarthritis, and musculoskeletal conditions. Photobiomodulation has a profound anti-inflammatory effect on immune cells, which can impact multiple body processes.
Considerations for clinicians and potential treatment options
Clinicians can consider integrating photobiomodulation therapy into their Parkinson's disease treatment plans. The study suggests treating patients with a combination of in-clinic and at-home therapy sessions. In-clinic treatment sessions can begin with three sessions per week for four weeks, followed by reducing frequency to twice a week for four weeks, and then once a week for the remaining four weeks. Patients can then continue at-home therapy sessions three times per week for an additional 40 to 25 weeks. Clinicians can explore using the Vylite Neurogamma device or other photobiomodulation devices within the recommended wavelength range of 800 to 830 nanometers and low doses. The therapy's safety and potential systemic effects make it an attractive option for managing Parkinson's disease.
Do you want to use light and laser therapy to help your patients with neurodegenerative symptoms? Dr. Rountree discusses research-based strategies to utilize photobiomodulation with this growing patient population.